StonvexLoading…
StonvexStonvexStonvexCore line items from PSMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-08-31 | Annual 2023 2023-08-31 | Annual 2022 2022-08-31 |
|---|---|---|---|---|
Revenue | $5.27B | $4.91B | $4.41B | $4.07B |
Operating Income | $232.51M | $220.94M | $184.52M | $167.07M |
Net Income | $147.89M | $138.88M | $109.20M | $104.53M |
EPS (Diluted) | $4.82 | $4.57 | $3.50 | $3.38 |
Total Assets | $2.27B | $2.02B | $2.01B | $1.81B |
Total Liabilities | $1.02B | $899.73M | $898.57M | $817.33M |
Cash & Equivalents | $241.02M | $125.36M | $239.98M | $237.71M |
Free Cash Flow OCF − CapEx | $103.17M | $39.04M | $114.82M | $1.17M |
Shares Outstanding | 30.75M | 30.64M | 30.98M | 30.90M |